Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer

References

• Bekeredjian R, Grayburn PA, Shohet RV. (2005). Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 45:329–35.
   PubMed Web of Science ®Google Scholar
• Caracciolo G, Callipo L, De Sanctis SC, et al. (2010). Surface adsorption of protein corona controls the cell internalization mechanism of DC-Chol-DOPE/DNA lipoplexes in serum. Biochim Biophys Acta 1798:536–43.
   PubMed Web of Science ®Google Scholar
• Christiansen JP, French BA, Klibanov AL, et al. (2003). Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 29:1759–67.
   PubMed Web of Science ®Google Scholar
• Chumakova OV, Liopo AV, Andreev VG, et al. (2008). Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett 261:215–25.
   PubMed Web of Science ®Google Scholar
• Fan X, Guo Y, Wang L, et al. (2016). Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles. Int J Nanomed 11:3939–50.
   PubMed Web of Science ®Google Scholar
• Farokhzad OC, Jo S, Khademhosseini A, et al. (2004). Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res 64:7668–72.
   PubMed Web of Science ®Google Scholar
• Faulhammer D, Eschgfaller B, Stark S, et al. (2004). Biostable aptamers with antagonistic properties to the neuropeptide nociceptin/orphanin FQ. RNA 10:516–27.
   PubMed Web of Science ®Google Scholar
• Green MR, Aya-Bonilla C, Gandhi MK, et al. (2011). Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes Cancer 50:313–26.
   PubMed Web of Science ®Google Scholar
• Greenleaf WJ, Bolander ME, Sarkar G, et al. (1998). Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 24:587–95.
   PubMed Web of Science ®Google Scholar
• He S, Cen B, Liao L, et al. (2017). A tumor-targeting cRGD-EGFR siRNA conjugate and its anti-tumor effect on glioblastoma in vitro and in vivo. Drug Deliv 24:471–81.
   PubMed Web of Science ®Google Scholar
• Huang Z, Pei W, Jayaseelan S, et al. (2007). RNA aptamers selected against the GluR2 glutamate receptor channel. Biochemistry 46:12648–55.
   PubMed Web of Science ®Google Scholar
• Jeong S, Lee HK, Kim MY. (2009). Use of RNA aptamers for the modulation of cancer cell signaling. Methods Mol Biol 542:363–77.
   PubMedGoogle Scholar
• Kalin TV, Ustiyan V, Kalinichenko VV. (2011). Multiple faces of FoxM1 transcription factor: lessons from transgenic mouse models. Cell Cycle 10:396–405.
   PubMed Web of Science ®Google Scholar
• Kalin TV, Wang IC, Ackerson TJ, et al. (2006). Increased levels of the FoxM1 transcription factor accelerate development and progression of prostate carcinomas in both TRAMP and LADY transgenic mice. Cancer Res 66:1712–20.
   PubMed Web of Science ®Google Scholar
• Li YS, Davidson E, Reid CN, et al. (2009). Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett 273:62–9.
   PubMed Web of Science ®Google Scholar
• Liu S, Guo W, Shi J, et al. (2012). MicroRNA-135a contributes to the development of portal vein Tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 56:389–96.
   PubMed Web of Science ®Google Scholar
• Lupold SE, Hicke BJ, Lin Y, et al. (2002). Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 62:4029–33.
   PubMed Web of Science ®Google Scholar
• Miller DL, Pislaru SV, Greenleaf JE. (2002). Sonoporation: mechanical DNA delivery by ultrasonic cavitation. Somat Cell Mol Genet 27:115–34.
   PubMedGoogle Scholar
• Nomikou N, Mchale AP. (2010). Exploiting ultrasound-mediated effects in delivering targeted, site-specific cancer therapy. Cancer Lett 296:133–43.
   PubMed Web of Science ®Google Scholar
• Nomikou N, Tiwari P, Trehan T, et al. (2012). Studies on neutral, cationic and biotinylated cationic microbubbles in enhancing ultrasound-mediated gene delivery in vitro and in vivo. Acta Biomater 8:1273–80.
   PubMed Web of Science ®Google Scholar
• Oh YK, Park TG. (2009). siRNA delivery systems for cancer treatment. Adv Drug Deliv Rev 61:850–62.
   PubMed Web of Science ®Google Scholar
• Panje CM, Wang DS, Pysz MA, et al. (2012). Ultrasound-mediated gene delivery with cationic versus neutral microbubbles: effect of DNA and microbubble dose on in vivo transfection efficiency. Theranostics 2:1078–91.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Luo Y, Zhang Y, et al. (2010). The correlation between acoustic cavitation and sonoporation involved in ultrasound-mediated DNA transfection with polyethylenimine (PEI) in vitro. J Control Release 145:40–8.
   PubMed Web of Science ®Google Scholar
• Rapoport N, Gao Z, Kennedy A. (2007). Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99:1095–106.
   PubMed Web of Science ®Google Scholar
• Ristau BT, O'Keefe DS, Bacich DJ. (2014). The prostate-specific membrane antigen: lessons and current clinical implications from 20 years of research. Urol Oncol 32:272–9.
   PubMed Web of Science ®Google Scholar
• Sun L, Huang CW, Wu J, et al. (2013). The use of cationic microbubbles to improve ultrasound-targeted gene delivery to the ischemic myocardium. Biomaterials 34:2107–16.
   PubMed Web of Science ®Google Scholar
• Tlaxca JL, Anderson CR, Klibanov AL, et al. (2010). Analysis of in vitro transfection by sonoporation using cationic and neutral microbubbles. Ultrasound Med Biol 36:1907–18.
   PubMed Web of Science ®Google Scholar
• Uddin S, Ahmed M, Hussain A, et al. (2011). Genome-wide expression analysis of Middle Eastern colorectal cancer reveals FOXM1 as a novel target for cancer therapy. Am J Pathol 178:537–47.
   PubMed Web of Science ®Google Scholar
• Wang CH, Kang ST, Lee YH, et al. (2012a). Aptamer-conjugated and drug-loaded acoustic droplets for ultrasound theranosis. Biomaterials 33:1939–47.
   PubMed Web of Science ®Google Scholar
• Wang DS, Panje C, Pysz MA, et al. (2012). Cationic versus neutral microbubbles for ultrasound-mediated gene delivery in cancer. Radiology 264:721–32.
   PubMed Web of Science ®Google Scholar
• Wang Y, Li X, Zhou Y, et al. (2010). Preparation of nanobubbles for ultrasound imaging and intracellular drug delivery. Int J Pharm 384:148–53.
   PubMed Web of Science ®Google Scholar
• Wang Y, Yao B, Wang Y, et al. (2014). Increased FoxM1 expression is a target for metformin in the suppression of EMT in prostate cancer. Int J Mol Med 33:1514–22.
   PubMed Web of Science ®Google Scholar
• Wang Z, Banerjee S, Kong D, et al. (2007). Down-regulation of Forkhead Box M1 transcription factor leads to the inhibition of invasion and angiogenesis of pancreatic cancer cells. Cancer Res 67:8293–300.
   PubMed Web of Science ®Google Scholar
• Xie A, Belcik T, Qi Y, et al. (2012). Ultrasound-mediated vascular gene transfection by cavitation of endothelial-targeted cationic microbubbles. JACC Cardiovasc Imaging 5:1253–62.
   PubMed Web of Science ®Google Scholar
• Xing Z, Wang J, Ke H, et al. (2010). The fabrication of novel nanobubble ultrasound contrast agent for potential tumor imaging. Nanotechnology 21:145607.
   PubMed Web of Science ®Google Scholar
• Yin T, Wang P, Li J, et al. (2013). Ultrasound-sensitive siRNA-loaded nanobubbles formed by hetero-assembly of polymeric micelles and liposomes and their therapeutic effect in gliomas. Biomaterials 34:4532–43.
   PubMed Web of Science ®Google Scholar
• Yin T, Wang P, Li J, et al. (2014). Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes. Biomaterials 35:5932–43.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Gu H, Xu Y, et al. (2015). Targeted antiangiogenesis gene therapy using targeted cationic microbubbles conjugated with CD105 antibody compared with untargeted cationic and neutral microbubbles. Theranostics 5:399–417.
   PubMed Web of Science ®Google Scholar